P56564
Gene name |
Slc1a3 (Eaat1, Gmt1) |
Protein name |
Excitatory amino acid transporter 1 |
Names |
Glial high affinity glutamate transporter, High-affinity neuronal glutamate transporter, GluT-1, Sodium-dependent glutamate/aspartate transporter 1, GLAST-1, Solute carrier family 1 member 3 |
Species |
Mus musculus (Mouse) |
KEGG Pathway |
mmu:20512 |
EC number |
|
Protein Class |
|
Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
1 structures for P56564
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| AF-P56564-F1 | Predicted | AlphaFoldDB |
38 variants for P56564
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
| rs239354846 | 18 | L>F | No | EVA | |
| rs3405307414 | 20 | Q>P | No | EVA | |
| rs256720684 | 35 | S>N | No | EVA | |
| rs3389355038 | 74 | S>I | No | EVA | |
| rs3389368332 | 74 | S>R | No | EVA | |
| rs3389274397 | 75 | Y>* | No | EVA | |
| rs3389342325 | 75 | Y>F | No | EVA | |
| rs3389333113 | 76 | R>G | No | EVA | |
| rs3389333090 | 102 | S>P | No | EVA | |
| rs3389348081 | 114 | K>* | No | EVA | |
| rs3389355064 | 114 | K>E | No | EVA | |
| rs3389355186 | 130 | T>N | No | EVA | |
| rs3389333161 | 137 | I>M | No | EVA | |
| rs3389355230 | 146 | H>Y | No | EVA | |
| rs3389350399 | 160 | K>N | No | EVA | |
| rs3389323563 | 162 | V>M | No | EVA | |
| rs3411653384 | 173 | L>S | No | EVA | |
| rs3389304522 | 189 | Q>K | No | EVA | |
| rs3405726771 | 217 | V>G | No | EVA | |
| rs3389342313 | 218 | S>* | No | EVA | |
| rs3389347753 | 220 | A>G | No | EVA | |
| rs3405307434 | 220 | A>S | No | EVA | |
| rs3405817753 | 222 | E>A | No | EVA | |
| rs3405855767 | 228 | R>L | No | EVA | |
| rs3389315996 | 257 | I>N | No | EVA | |
| rs3389323583 | 262 | E>* | No | EVA | |
| rs3389314722 | 278 | I>T | No | EVA | |
| rs3389350374 | 301 | I>T | No | EVA | |
| rs3389350431 | 325 | L>R | No | EVA | |
| rs3389355012 | 351 | G>W | No | EVA | |
| rs3389347786 | 358 | T>I | No | EVA | |
| rs3389333110 | 372 | T>I | No | EVA | |
| rs3389354982 | 384 | K>R | No | EVA | |
| rs3389368380 | 391 | L>F | No | EVA | |
| rs3389347779 | 401 | G>V | No | EVA | |
| rs3389314705 | 409 | A>V | No | EVA | |
| rs3389333101 | 414 | A>T | No | EVA | |
| rs3389362520 | 439 | G>V | No | EVA |
No associated diseases with P56564
2 regional properties for P56564
| Type | Name | Position | InterPro Accession |
|---|---|---|---|
| conserved_site | Sodium:dicarboxylate symporter, conserved site | 84 - 98 | IPR018107-1 |
| conserved_site | Sodium:dicarboxylate symporter, conserved site | 392 - 415 | IPR018107-2 |
13 GO annotations of cellular component
| Name | Definition |
|---|---|
| basal plasma membrane | The region of the plasma membrane located at the basal end of the cell. Often used in reference to animal polarized epithelial membranes, where the basal membrane is the part attached to the extracellular matrix, or in plant cells, where the basal membrane is defined with respect to the zygotic axis. |
| basolateral plasma membrane | The region of the plasma membrane that includes the basal end and sides of the cell. Often used in reference to animal polarized epithelial membranes, where the basal membrane is the part attached to the extracellular matrix, or in plant cells, where the basal membrane is defined with respect to the zygotic axis. |
| cell periphery | The part of a cell encompassing the cell cortex, the plasma membrane, and any external encapsulating structures. |
| cell projection | A prolongation or process extending from a cell, e.g. a flagellum or axon. |
| cell surface | The external part of the cell wall and/or plasma membrane. |
| dendritic spine | A small, membranous protrusion from a dendrite that forms a postsynaptic compartment, typically receiving input from a single presynapse. They function as partially isolated biochemical and an electrical compartments. Spine morphology is variable:they can be thin, stubby, mushroom, or branched, with a continuum of intermediate morphologies. They typically terminate in a bulb shape, linked to the dendritic shaft by a restriction. Spine remodeling is though to be involved in synaptic plasticity. |
| integral component of plasma membrane | The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane. |
| membrane protein complex | Any protein complex that is part of a membrane. |
| mitochondrial inner membrane | The inner, i.e. lumen-facing, lipid bilayer of the mitochondrial envelope. It is highly folded to form cristae. |
| neuron projection | A prolongation or process extending from a nerve cell, e.g. an axon or dendrite. |
| neuronal cell body | The portion of a neuron that includes the nucleus, but excludes cell projections such as axons and dendrites. |
| plasma membrane | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |
| synapse | The junction between an axon of one neuron and a dendrite of another neuron, a muscle fiber or a glial cell. As the axon approaches the synapse it enlarges into a specialized structure, the presynaptic terminal bouton, which contains mitochondria and synaptic vesicles. At the tip of the terminal bouton is the presynaptic membrane; facing it, and separated from it by a minute cleft (the synaptic cleft) is a specialized area of membrane on the receiving cell, known as the postsynaptic membrane. In response to the arrival of nerve impulses, the presynaptic terminal bouton secretes molecules of neurotransmitters into the synaptic cleft. These diffuse across the cleft and transmit the signal to the postsynaptic membrane. |
8 GO annotations of molecular function
| Name | Definition |
|---|---|
| acidic amino acid transmembrane transporter activity | Enables the transfer of acidic amino acids from one side of a membrane to the other. Acidic amino acids have side chains with a negative charge at pH 7.3. |
| amino acid binding | Binding to an amino acid, organic acids containing one or more amino substituents. |
| glutamate binding | Binding to glutamate, the anion of 2-aminopentanedioic acid. |
| glutamate:sodium symporter activity | Enables the transfer of a solute or solutes from one side of a membrane to the other according to the reaction: glutamate(out) + Na+(out) = glutamate(in) + Na+(in). |
| high-affinity L-glutamate transmembrane transporter activity | Enables the transfer of glutamate from one side of a membrane to the other. In high-affinity transport the transporter is able to bind the solute even if it is only present at very low concentrations. |
| L-glutamate transmembrane transporter activity | Enables the transfer of L-glutamate from one side of a membrane to the other. L-glutamate is the anion of 2-aminopentanedioic acid. |
| metal ion binding | Binding to a metal ion. |
| neutral amino acid transmembrane transporter activity | Enables the transfer of neutral amino acids from one side of a membrane to the other. Neutral amino acids have side chains with no charge at pH 7.3. |
23 GO annotations of biological process
| Name | Definition |
|---|---|
| auditory behavior | The behavior of an organism in response to a sound. |
| cell morphogenesis involved in neuron differentiation | The process in which the structures of a neuron are generated and organized. This process occurs while the initially relatively unspecialized cell is acquiring the specialized features of a neuron. |
| cellular response to cocaine | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cocaine stimulus. Cocaine is a crystalline alkaloid obtained from the leaves of the coca plant. |
| cellular sodium ion homeostasis | Any process involved in the maintenance of an internal steady state of sodium ions at the level of a cell. |
| chloride transmembrane transport | The process in which chloride is transported across a membrane. |
| cranial nerve development | The process whose specific outcome is the progression of the cranial nerves over time, from its formation to the mature structure. The cranial nerves are composed of twelve pairs of nerves that emanate from the nervous tissue of the hindbrain. These nerves are sensory, motor, or mixed in nature, and provide the motor and general sensory innervation of the head, neck and viscera. They mediate vision, hearing, olfaction and taste and carry the parasympathetic innervation of the autonomic ganglia that control visceral functions. |
| D-aspartate import across plasma membrane | The directed import of D-aspartate from the extracellular region across the plasma membrane and into the cytosol. |
| gamma-aminobutyric acid biosynthetic process | The chemical reactions and pathways resulting in the formation of gamma-aminobutyric acid (GABA, 4-aminobutyrate), an amino acid which acts as a neurotransmitter in some organisms. |
| L-aspartate import across plasma membrane | The directed movement of L-aspartate from outside of a cell, across the plasma membrane and into the cytosol. |
| L-glutamate import | The directed movement of L-glutamate, the L-enantiomer of the anion of 2-aminopentanedioic acid, into a cell or organelle. |
| L-glutamate import across plasma membrane | The directed movement of L-glutamate from outside of a cell, across the plasma membrane and into the cytosol. |
| L-glutamate transmembrane transport | The directed movement of L-glutamate across a membrane. |
| malate-aspartate shuttle | The process of transferring reducing equivalents from the cytosol into the mitochondria; NADH is used to synthesise malate in the cytosol; this compound is then transported into the mitochondria where it is converted to oxaloacetate using NADH, the oxaloacetate reacts with gluamate to form aspartate, and the aspartate then returns to the cytosol to complete the cycle. |
| neuromuscular process controlling balance | Any process that an organism uses to control its balance, the orientation of the organism (or the head of the organism) in relation to the source of gravity. In humans and animals, balance is perceived through visual cues, the labyrinth system of the inner ears and information from skin pressure receptors and muscle and joint receptors. |
| positive regulation of synaptic transmission | Any process that activates or increases the frequency, rate or extent of synaptic transmission, the process of communication from a neuron to a target (neuron, muscle, or secretory cell) across a synapse. |
| potassium ion transmembrane transport | A process in which a potassium ion is transported from one side of a membrane to the other. |
| response to amino acid | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an amino acid stimulus. An amino acid is a carboxylic acids containing one or more amino groups. |
| response to antibiotic | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an antibiotic stimulus. An antibiotic is a chemical substance produced by a microorganism which has the capacity to inhibit the growth of or to kill other microorganisms. |
| response to inorganic substance | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an inorganic substance stimulus. |
| response to light stimulus | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a light stimulus, electromagnetic radiation of wavelengths classified as infrared, visible or ultraviolet light. |
| response to wounding | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating damage to the organism. |
| response to xenobiotic stimulus | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from a xenobiotic, a compound foreign to the organim exposed to it. It may be synthesized by another organism (like ampicilin) or it can be a synthetic chemical. |
| sensory perception of sound | The series of events required for an organism to receive an auditory stimulus, convert it to a molecular signal, and recognize and characterize the signal. Sonic stimuli are detected in the form of vibrations and are processed to form a sound. |
5 homologous proteins in AiPD
| UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
|---|---|---|---|---|
| P46411 | SLC1A3 | Excitatory amino acid transporter 1 | Bos taurus (Bovine) | PR |
| P43003 | SLC1A3 | Excitatory amino acid transporter 1 | Homo sapiens (Human) | PR |
| O35544 | Slc1a6 | Excitatory amino acid transporter 4 | Mus musculus (Mouse) | PR |
| Q8JZR4 | Slc1a7 | Excitatory amino acid transporter 5 | Mus musculus (Mouse) | PR |
| P24942 | Slc1a3 | Excitatory amino acid transporter 1 | Rattus norvegicus (Rat) | PR |
| 10 | 20 | 30 | 40 | 50 | 60 |
| MTKSNGEEPR | MGGRMERLQQ | GVRKRTLLAK | KKVQSLTKED | VKSYLFRNAF | VLLTVTAVIV |
| 70 | 80 | 90 | 100 | 110 | 120 |
| GTILGFALRP | YKMSYREVKY | FSFPGELLMR | MLQMLVLPLI | ISSLVTGMAA | LDSKASGKMG |
| 130 | 140 | 150 | 160 | 170 | 180 |
| MRAVVYYMTT | TIIAVVIGII | IVIIIHPGKG | TKENMYREGK | IVQVTAADAF | LDLIRNMFPP |
| 190 | 200 | 210 | 220 | 230 | 240 |
| NLVEACFKQF | KTSYEKRSFK | VPIQSNETLL | GAVINNVSEA | METLTRIREE | MVPVPGSVNG |
| 250 | 260 | 270 | 280 | 290 | 300 |
| VNALGLVVFS | MCFGFVIGNM | KEQGQALREF | FDSLNEAIMR | LVAVIMWYAP | LGILFLIAGK |
| 310 | 320 | 330 | 340 | 350 | 360 |
| IVEMEDMGVI | GGQLAMYTVT | VIVGLLIHAV | IVLPLLYFLV | TRKNPWVFIG | GLLQALITAL |
| 370 | 380 | 390 | 400 | 410 | 420 |
| GTSSSSATLP | ITFKCLEENN | GVDKRITRFV | LPVGATINMD | GTALYEALAA | IFIAQVNNFD |
| 430 | 440 | 450 | 460 | 470 | 480 |
| LNFGQIITIS | ITATAASIGA | AGIPQAGLVT | MVIVLTSVGL | PTDDITLIIA | VDWFLDRLRT |
| 490 | 500 | 510 | 520 | 530 | 540 |
| TTNVLGDSLG | AGIVEHLSRH | ELKNRDVEMG | NSVIEENEMK | KPYQLIAQDN | EPEKPVADSE |
| TKM |